↓ Skip to main content

Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
10 news outlets
twitter
63 X users
facebook
2 Facebook pages

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)
Published in
Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, February 2018
DOI 10.1161/jaha.117.007633
Pubmed ID
Authors

Benjamin A. Steinberg, Peter Shrader, Karen Pieper, Laine Thomas, Larry A. Allen, Jack Ansell, Paul S. Chan, Michael D. Ezekowitz, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini, the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II Investigators

X Demographics

X Demographics

The data shown below were collected from the profiles of 63 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 159 100%

Demographic breakdown

Readers by professional status Count As %
Other 22 14%
Researcher 21 13%
Student > Ph. D. Student 19 12%
Student > Postgraduate 10 6%
Student > Master 10 6%
Other 23 14%
Unknown 54 34%
Readers by discipline Count As %
Medicine and Dentistry 60 38%
Pharmacology, Toxicology and Pharmaceutical Science 14 9%
Agricultural and Biological Sciences 4 3%
Biochemistry, Genetics and Molecular Biology 2 1%
Computer Science 2 1%
Other 9 6%
Unknown 68 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 110. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2018.
All research outputs
#385,187
of 25,634,695 outputs
Outputs from Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease
#481
of 8,377 outputs
Outputs of similar age
#8,902
of 351,072 outputs
Outputs of similar age from Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease
#9
of 238 outputs
Altmetric has tracked 25,634,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,377 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,072 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.